- Home
- ELS vs QGEN Comparison
ELS vs QGEN Comparison
Compare ELS & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELS | QGEN |
|---|---|---|
| Founded | 1992 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 10.2B |
| IPO Year | 1993 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ELS | QGEN |
|---|---|---|
| Price | $61.66 | $47.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 7 |
| Target Price | ★ $70.86 | $50.68 |
| AVG Volume (30 Days) | ★ 1.5M | 1.2M |
| Earning Date | 01-26-2026 | 11-04-2025 |
| Dividend Yield | ★ 3.34% | 3.21% |
| EPS Growth | 2.36 | ★ 331.20 |
| EPS | ★ 1.99 | 1.84 |
| Revenue | $1,535,911,000.00 | ★ $2,070,781,000.00 |
| Revenue This Year | $1.02 | $7.12 |
| Revenue Next Year | $4.52 | $6.13 |
| P/E Ratio | $30.95 | ★ $25.56 |
| Revenue Growth | 0.93 | ★ 5.32 |
| 52 Week Low | $58.15 | $37.63 |
| 52 Week High | $70.55 | $51.88 |
Technical Indicators
Market Signals| Indicator | ELS | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 45.91 | 55.46 |
| Support Level | $61.11 | $46.39 |
| Resistance Level | $62.84 | $48.13 |
| Average True Range (ATR) | 0.92 | 0.67 |
| MACD | -0.08 | 0.18 |
| Stochastic Oscillator | 18.86 | 68.53 |
Price Performance
Historical ComparisonAbout ELS Equity Lifestyle Properties Inc.
Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently has a portfolio of 455 properties across the U.S. with a higher concentration in the Sunbelt region with 38% of the company's properties located in Florida, 12% in Arizona, and 8% in California. Equity Lifestyle targets owning properties in attractive retirement destinations with over 70% of the company's properties either being age-restricted or having an average resident age over 55.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).